Evidence map›Paper›PMID 34129225›Full record

ArticleJournal of physiology and biochemistry2021

Metformin reverses the effects of high glucose on human dermal fibroblasts of aged skin via downregulating RELA/p65 expression.

Tugba Soydas, Muge Sayitoglu, Elif Yaprak Sarac, Suzan Cınar, Seyhun Solakoglu, Tunc Tiryaki, Gonul Kanıgur Sultuybek

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Skin Aging and the Upcoming Role of Ferroptosis in Geroscience.International journal of molecular sciences · 2024
    Review
  12. Research Progress in Skin Aging, Metabolism, and Related Products.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Modeling of the Senescence-Associated Phenotype in Human Skin Fibroblasts.International journal of molecular sciences · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tugba SoydasDepartment of Medical Biology and Genetics, Medical Faculty, Istanbul Aydin University, Istanbul, Turkey.
Muge SayitogluDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Elif Yaprak SaracDepartment of Histology and Embryology Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Suzan CınarDepartment of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Seyhun SolakogluDepartment of Histology and Embryology Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Tunc TiryakiDepartment of Plastic Surgery, Cellest Plastic Surgery Clinic, Istanbul, Turkey.
Gonul Kanıgur SultuybekDepartment of Medical Biology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. kanigur@istanbul.edu.tr.ORCID http://orcid.org/0000-0001-8420-9298
Istanbul University · TRIstanbul Aydın University · TRIstanbul University-Cerrahpaşa · TR

Funding

Scientific Research Project Coordination Unit of Istanbul University(TR) 21204
6 · The paper itself

Abstract

Metformin has been successfully used as an anti-aging agent but exact molecular mechanisms of metformin in anti-aging remain unknown. Hyperglycemia during skin aging not only causes oxidative damage to cellular macromolecules, like dermal collagen, but also modulates the activation of transcription factor nuclear factor kappa B (NF-kB). We aimed to investigate in vitro effects of high glucose (HG) and metformin treatment on proliferation and apoptosis of human primary dermal fibroblasts (HDFs), and the expression of COL1A1, COL3A1, and RELA/p65 genes. Effects of normal glucose (5.5 mM) and HG concentration (50 mM HG) on HDFs, with two doses of metformin (50 μM and 500 μM), were investigated by immunostaining. Apoptotic levels were analyzed by flow cytometry. Expression of COL1A1, COL3A1, and RELA/p65 genes was measured by quantitative real-time PCR. The proliferation of HDFs was decreased significantly (P < 0.01) and expression of COL1A1 was downregulated by HG without metformin, whereas proliferation was elevated and expression was upregulated with 500 μM metformin + HG compared to 5.5 mM glucose (P < 0.05). The expression of COL3A1 and RELA/p65 were upregulated (P < 0.01 for COL3A1), and percentage of late apoptotic cells increased significantly by HG without metformin (P < 0.001) while it decreased in two concentrations of metformin dramatically compared with 5.5 mM glucose (P < 0.01 for expressions and < 0.001 for apoptosis). Metformin not only significantly downregulated RELA/p65 expression, but also inhibited the apoptosis of HDFs from aged human skin at toxic glucose concentrations which could be inversely mediated via COL1A1 and COL3A1 expression.

Indexed as

ApoptosisCells, CulturedDown-RegulationFemaleFibroblastsGlucoseHumansMetforminMiddle AgedPrimary Cell CultureSkinSkin AgingTranscription Factor RelAGlucoseMetforminRELA protein, humanTranscription Factor RelAAgingApoptosisCollagenHuman primary dermal fibroblastsMetforminNF-kB

Identifiers

PMID34129225
OpenAlexW3169706888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.